BioTime Inc.

(BTX)

By |

Profile

BioTime Inc is a clinical-stage biotechnology company. Its objective is the development and commercialization of novel therapies developed with the help of the company's core technology platforms. The core therapeutic technologies are based on pluripotent stem cells that can become any of the cell types in the human body. Pluripotent stem cells have potential applications in many areas of medicine, including several age-related degenerative diseases and conditions for which there presently are no cures. The product portfolio includes Renevia, a potential treatment for HIV-related facial lipoatrophy; AST-VAC1, a cancer immunotherapy; and OpRegen, a potential therapy derived from pluripotent stem cells to treat the dry form of age-related macular degeneration.

Contact Information

Website: www.biotime.com
Email: dlawrence@biotimeinc.com
Main Phone: +1 510 521-3390
Address: 1010 Atlantic Avenue
Address 2: Suite 102
State: CA
City / Town: Alameda
Country: USA
Postal Code: 94501

Issuer Information

Exchange: AMX
CEO: Brian M. Culley
Employees: 95
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

BioTime Inc is a clinical-stage biotechnology company. Its objective is the development and commercialization of novel therapies developed with the help of the company's core technology platforms. The core therapeutic technologies are based on pluripotent stem cells that can become any of the cell types in the human body. Pluripotent stem cells have potential applications in many areas of medicine, including several age-related degenerative diseases and conditions for which there presently are no cures. The product portfolio includes Renevia, a potential treatment for HIV-related facial lipoatrophy; AST-VAC1, a cancer immunotherapy; and OpRegen, a potential therapy derived from pluripotent stem cells to treat the dry form of age-related macular degeneration.

Contact Information

Website: www.biotime.com
Email: dlawrence@biotimeinc.com
Main Phone: +1 510 521-3390
Address: 1010 Atlantic Avenue
Address 2: Suite 102
State: CA
City / Town: Alameda
Country: USA
Postal Code: 94501

Issuer Information

Exchange: AMX
CEO: Brian M. Culley
Employees: 95
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 1.12 $ 0. (0.00%)
Last Price 1.12 Change $ 0. Change % 0.00 Tick N/A
Bid 1.10 Bid Size 100.00 Ask 1.11 Ask Size 1,900.00
Open N/A High N/A Low N/A Prev Close 1.12
Last Trade Volume 1,925 52 Wk Hi 3.16 52 Wk Low 0.66
Market Cap 142.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 126,964,037.00 EPS (TTM) -0.64 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 35
Number of Buys 2 25
Number of Sells 2 10
Net Activity 4088 391791
Last 10 Buys Shares
Russell L. Skibsted 1,000
Michael D. West 1,000
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Deborah Andrews 1,000
Aditya Mohanty 1,000
Stephana Patton 1,000
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Deborah Andrews 1,000
Last 10 Sell Shares
Alfred D. Kingsley 1,000
Alfred D. Kingsley 1,000
Alfred D. Kingsley 1,000
Michael D. West 1,000
Robert W. Peabody 1,000
William P. Tew 1,000
William P. Tew 1,000
William P. Tew 1,000
Alfred D. Kingsley 1,000
Alfred D. Kingsley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 6.63 6.63 6.63 6.63
Standard Deviation 0.95 0.95 0.95 0.95
Date of Most Recent Estimate 05/24/18 05/24/18 05/22/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 4
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.25 1.25 1.2